Urged By US FDA To Boost Infant Formula Supply, Additional Providers Still Must Wait For Approval
Patricia Hansen, CFSAN’s Office of Nutrition and Food Labeling deputy director and John Verbeten, deputy director for Import Operations Enforcement laid out the FDA's new enforcement guidance, and urged businesses with available formula to wait for approval before distributing formula in the US.
You may also be interested in...
Chairwoman Lina Khan was careful to note FTC isn’t investigating Abbott Nutrition’s manufacturing practices, its recall of products and shutdown of a plant and the supply shortage that followed.
"Many of the problems facing [the FDA] can be solved through strong leadership rather than more money,” says Rep. Andy Harris during Appropriations subcommittee hearing, Committee Chairwoman Rosa DeLauro continues her criticism of FDA's regulation of industries under its oversight, saying a "structural problem" caused infant formula shortage.
Commissioner Robert Califf wants Janet Woodcock to improve food operations and processes, but lawmakers question whether she is the best overseer for the area.